Mink Therapeutics Inc
NASDAQ:INKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
D
|
Deere & Co
F:DCO
|
US |
|
Truworths International Ltd
F:IUE
|
ZA |
|
Rarex Ltd
ASX:REE
|
AU |
|
I
|
IDT Corp
XMUN:IDC2
|
US |
|
Energy of Minas Gerais Co
BOVESPA:CMIG4
|
BR |
|
C
|
CME Group Inc
XMUN:MX4A
|
US |
|
Carlisle Companies Inc
NYSE:CSL
|
US |
|
B
|
Biogen Inc
XMUN:IDP
|
US |
|
Xiaomi Corp
F:3CPA
|
CN |
|
Nongfu Spring Co Ltd
F:7NF
|
CN |
Wall St Price Targets
INKT Price Targets Summary
Mink Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INKT's stock price target?
Price Target
39.78
USD
According to Wall Street analysts, the average 1-year price target for
INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.